SL Science Holding Ltd
corporate_fare Company Profile
SL Science Holding Ltd (NASDAQ:SLBT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for SLBT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-26, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for SLBT spans 6-K, SCHEDULE 13D, 20-F.
Recent high-impact activity:
- SL Science Posts H1 2026: Revenue Up 23%, Net Loss Widens to $2.16M
- SL Science Replaces ARK Pro CPA with TAAD LLP as Independent Auditor
- SL Science Seeks FDA Orphan Drug Designation for GDT Cell Therapy in Glioblastoma
- Newly Public SL Science Reports 35% Revenue Drop, 221% Net Loss Increase for FY2025
- CEO & Chairman Discloses 59.53% Controlling Stake Post-SPAC Merger
Short Interest & Short Volume
1.41 days to coverFINRA reported short interest of 49,966 shares in SLBT as of the October 30, 2026 settlement, a 36.6% increase from the prior period — about 1.4 days to cover at its recent average daily volume. On November 20, 2026, 44.7% of SLBT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for SLBT, detected from its recent SEC filings.
Resale Registration Filed · Lock-Up Expiration
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
SLBT files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.